FDA Says Pfizer Coronavirus Vaccine Is Safe.
The U.S. Food and Drug Administration published its initial findings concerning the vaccine in briefing documents on Tuesday.
[The Pfizer vaccine shows] a favorable safety profile, with no specific safety concerns, FDA Briefing Documents, via Politico.
Pfizer is seeking emergency use approval of its vaccine from the FDA.
Data from Pfizer shows a swift immune response in patients to the vaccine following the first of two doses.
The data shows efficacy of the vaccine against severe COVID-19 cases to be 88 percent following the first dose, .
And then 95 percent following the second.
The independent vaccine advisory committee of the FDA is scheduled to meet on Thursday.
A decision regarding approval of the Pfizer vaccine could follow at any time following that meeting.
The U.K. became the first Western nation to begin vaccinating its citizens on Tuesday
